Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Adam

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cutis|December 6, 2008
Review of intravascular lymphoma with a report of treatment with allogenic peripheral blood stem cell transplantDavid N Adam, Kathryn M Beleznay, Roop S Randhawa, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine usersKaterina Pavenski, Hilde Vandenberghe, Henry Jakubovic, et al.
Journal of Cutaneous Medicine and Surgery|October 11, 2008
Efficacy of a day-care program in the treatment of psoriasisJunling Zhang, David N Adam, Elaine Stebbing, et al.
Skin Therapy Letter|April 6, 2022
Transition of Topical Therapy Formulation in Psoriasis: Insights from a Canadian Practice ReflectiveDavid N Adam, Sonya J Abdulla, Patrick Fleming, et al.
American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
JAAD International|February 3, 2025
Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusGeeta Yadav, Yvette Miller-Monthrope, Jaggi Rao, et al.
Journal of the American Academy of Dermatology|March 31, 2024
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trialLinda Stein Gold, David N Adam, Lorne Albrecht, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cutis|December 6, 2008
Review of intravascular lymphoma with a report of treatment with allogenic peripheral blood stem cell transplantDavid N Adam, Kathryn M Beleznay, Roop S Randhawa, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine usersKaterina Pavenski, Hilde Vandenberghe, Henry Jakubovic, et al.
Journal of Cutaneous Medicine and Surgery|October 11, 2008
Efficacy of a day-care program in the treatment of psoriasisJunling Zhang, David N Adam, Elaine Stebbing, et al.
Skin Therapy Letter|April 6, 2022
Transition of Topical Therapy Formulation in Psoriasis: Insights from a Canadian Practice ReflectiveDavid N Adam, Sonya J Abdulla, Patrick Fleming, et al.
American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
JAAD International|February 3, 2025
Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusGeeta Yadav, Yvette Miller-Monthrope, Jaggi Rao, et al.
Journal of the American Academy of Dermatology|March 31, 2024
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trialLinda Stein Gold, David N Adam, Lorne Albrecht, et al.
Pageof 2